Skip to main content

Part of the book series: HNO Praxis heute ((HNO,volume 26))

  • 646 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Roche Lexikon der Medizin (1993) Fokus/Fokaltoxikose. Urban Schwarzenberg, München Wien Baltimore, S 562

    Google Scholar 

  2. Giertz H, Flohe L, Peskar A, Resch K (1992) Mediatoren der Entzündung und Allergie in Pharmakologie und Toxikologie. In: Fort H, Henschler D, Rummel W, Starke K (Hrsg) Allgemeine Pharmakologie und Toxikologie BI Wisenschaftsverlag, Mannheim Leipzig Wien Zürich, S 304–344

    Google Scholar 

  3. Milne GL, Musiek ES, Morrow JD (2005) F(2)-Isoprostanes as markers of oxidative stress in vivo: An overview. Biomarkers 10Suppl 1: 10–23.

    Article  CAS  Google Scholar 

  4. Loesche W, Grossman N (V2001) Periodontal disease as a specific albeit chronic infection. Diagnosis and treatment. Clin Microbiol Rev 727–752

    Google Scholar 

  5. Danesh J, Collins R, Peto R (1997) Chronic infection and coronary heart disease. Is there a link? Lancet 350: 430–436

    Article  PubMed  CAS  Google Scholar 

  6. Buckley RH (2004) Pulmonary complications of primary immunodeficiencies. Paediatr Respir Rev 5,Suppl A: 225–233

    Article  Google Scholar 

  7. Horn ME, Reed SE, Taylor PE (1979) Role of viruses and bacteria in acute wheezy bronchitis in childhood. A study of sputum. Arch Dis Child 54: 587–592

    PubMed  CAS  Google Scholar 

  8. Ring C, Carrol D, Hoving J et al (2005) Effects of competition, exercise, and mental stress on secretory immunity. J Sports Sci 23(5): 501–5088

    Article  PubMed  Google Scholar 

  9. Hagashi M. (1994) Adhärenz von Streptococcus pyogenes an Wangenschleimhautepithelien bei Kindern mit rezidivierenden Streoptokokkeninfektionen. Dissertation Univ Erlangen

    Google Scholar 

  10. Ruder H, Thurn CH, Guggenbichler JP (1992) Adherence of E. coli to uroepithelia in children and adolescents after renal transplantation. Transplant Proc 24: 2576–2577

    PubMed  CAS  Google Scholar 

  11. Hagen P, Hobisch A, Guggenbichler JP et al. (1992) Korrelation von vesiko-ureteralem Reflux und rezidivierenden Harnwegsinfektionen mit erhöhter bakterieller Adhärenz. Urologe 31: 186–188

    PubMed  CAS  Google Scholar 

  12. Schröder J (1999) Antimikrobielle Peptide — Antibiotika der Zukunft MMP 22: 270–277

    Google Scholar 

  13. Brandtzaeg P (1988) Mucosal immunology: with special reference to specific immune defense of upper respiratory tract. Otolaryngology 50: 225–235

    CAS  Google Scholar 

  14. Benesch KW; Raida M, Mägert HJ et al. (1995) A novel β Defensin from human plasma. FEBS Letter 368: 331–335

    Article  Google Scholar 

  15. Hancock RE (1997) Peptide antibiotics. Lancet 349, 418–422

    Article  PubMed  CAS  Google Scholar 

  16. Medzhitov R, Janeway C (2000) Innate immune recognition: mechanisms and pathways. Immunol Review 173: 89–97

    Article  CAS  Google Scholar 

  17. Medzhitov R (2001) Toll like receptors and innate immunity. Nature Reviews 1: 135–145

    Article  PubMed  CAS  Google Scholar 

  18. Barton GM, Medzhitov R (2002) Control of adaptive immune responses by Toll like receptors. Curr Opin Immunol 14: 380–383

    Article  PubMed  CAS  Google Scholar 

  19. Dagan R, Klugman KP, Craig WA, Baquero F (2001) Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy. J Antimic Chemoth 47: 129–140

    Article  CAS  Google Scholar 

  20. Dagan R, Leibovitz E, Greenberg D et al. (1998) Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved outcome. Pediatric Infectious Dis. Journal 17: 778–782

    Google Scholar 

  21. Hobermann A, Wald ER, Hickey RW (1999) Oral versus initial intravenous therapy of acute urinary tract infections in young febrile children. Pediatrics 104: 79–86

    Article  Google Scholar 

  22. Guggenbichler JP, Kienel G (1978) Pharmakokinetische Untersuchung mit neuen galenische Zubereitungen von Cephalexin. Päd Pädol 13: 315–320

    CAS  Google Scholar 

  23. Guggenbichler JP (1982) Resorption oral verabreichter Antibiotika und Chemotherapeutika bei Kindern und ihre Beeinflussung. Päd Pädol 17: 565–584

    CAS  Google Scholar 

  24. Jürgens, UR, Stöber M, Vetter H (1998) Steroidartige Hemmung des monozytären Arachidonsäuremetabolismus und der IL 1 Produktion durch 1,8-Cineol. Atemw. Lungenkrkh 1: 2–10

    Google Scholar 

  25. Cvoriscec B, Ustar M, Pardon R et al. (1989) Oral Immunotherapy of chronic bronchitis: a double blind placebo controlled multicentre study. Respiration 55: 129–135

    Article  PubMed  CAS  Google Scholar 

  26. Gutierrez-Tarango MD, Berber A (1997) Efficacy of a bacterial extract (OM-85 BV) in preventing recurrent respiratory tract infections in susceptible children. Clin Drug Invest 13: 76–84

    Google Scholar 

  27. Maestroni GJ, Losa GA (1984) Clinical and immunobiological effects of an orally administered bacterial extract. Int J Immunopharmacol 111–117

    Google Scholar 

  28. Fischer H, Eckenberg P, Van Aubel A et al (1992). Prävention von Infektrezidiven der oberen und unteren Luftwege. Atemw u Lungenkrankh 18: 146–155

    Google Scholar 

  29. Wichels M, Wolfschaffner H (1996) Dissertation zur Erlangung des med. Doktorgrades, Univ. Erlangen: Stimulation des sekretions Ig A Systems durch Bakterienlysate und Blockierung der Adhärenz von Mikroorganismen an Schleimhautepithelien. TW Pädiatrie 9: 521–523

    Google Scholar 

  30. Maune St, Meyer JE (2001) Potenzial körpereigener antibiotischer Peptide bei der angeborenen Abwehr von Rhinusinusitiden. Allergologie 24: 23–32

    Google Scholar 

  31. Mackay I, Rosen F (2000) Innate immunity New Engl J Med 343: 338–344

    Google Scholar 

  32. Fleming A (1922) On a remarkable bacteriolytic element founding tissues and secretions. Proc R Soc London 93: 306–317

    Article  CAS  Google Scholar 

  33. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz (1999) Phylogenetic perspectives in innate immunity. Science 284: 1313–1318

    Article  PubMed  CAS  Google Scholar 

  34. Fulton C, Anderson GM, Stolzenberg Ed et al. (1997) Human β Defensin 1 is a salt sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88: 553–560

    Article  Google Scholar 

  35. Medzhitov R, Janeway CG (2000) Innate Immunity in Advances Immunology. New Engl J Med 338: 338–344

    Article  Google Scholar 

  36. Fan J, Kapuis A, Marsden PA et al. (2002) Regulation of Tolllike receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharides. J Immunology 168: 5252–5259

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Guggenbichler, J.P. (2006). Der Fokus in der Pädiatrie. In: Biesinger, E., Iro, H. (eds) Der Fokus im HNO-Bereich: Fakt oder Fiktion?. HNO Praxis heute, vol 26. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30681-1_8

Download citation

  • DOI: https://doi.org/10.1007/3-540-30681-1_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-30680-1

  • Online ISBN: 978-3-540-30681-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics